Page last updated: 2024-08-24

isocytosine and allopurinol

isocytosine has been researched along with allopurinol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
B-Rao, C; Bahirat, U; Brahma, MK; Deshmukh, NJ; Dixit, A; Doshi, L; Ghosh, U; Katkar, KV; Keche, A; Khanna, S; Korde, V; Kulkarni-Almeida, A; Nemmani, KV; Shah, P; Sharma, R; Sivaramakrishnan, H; Srivastava, A1
B-Rao, C; Bahirat, U; Bajaj, K; Brahma, MK; Burudkar, S; Damre, A; Desai, A; Deshmukh, NJ; Dixit, A; Doshi, L; Ghosh, U; Keche, A; Khanna, S; Kulkarni-Almeida, A; Nemmani, KV; Shah, P; Sharma, R; Sivaramakrishnan, H; Srivastava, A; Tannu, P1
Ahire, Y; B-Rao, C; Bajaj, K; Burudkar, S; Damre, A; Deshmukh, NJ; Dixit, A; Ghosh, U; Keche, A; Khanna, S; Kulkarni-Almeida, A; Nemmani, KV; Shah, P; Sharma, R; Sivaramakrishnan, H; Srivastava, A; Tannu, P1
Abbot, V; Gupta, MK; Narang, BK; Rawal, RK; Roy, S; Singh, V1

Other Studies

4 other study(ies) available for isocytosine and allopurinol

ArticleYear
Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits.
    Bioorganic & medicinal chemistry, 2012, May-01, Volume: 20, Issue:9

    Topics: Animals; Computer Simulation; Cytosine; Enzyme Activation; Enzyme Inhibitors; Hyperuricemia; Male; Oxonic Acid; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Xanthine Oxidase

2012
Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Administration, Oral; Animals; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Hyperuricemia; Models, Molecular; Molecular Structure; Rats; Rats, Sprague-Dawley; Rats, Wistar; Structure-Activity Relationship; Time Factors; Xanthine Oxidase

2012
Lead optimization of isocytosine-derived xanthine oxidase inhibitors.
    Bioorganic & medicinal chemistry letters, 2013, Feb-01, Volume: 23, Issue:3

    Topics: Administration, Oral; Animals; Catalytic Domain; Cytosine; Enzyme Activation; Enzyme Inhibitors; Inhibitory Concentration 50; Models, Animal; Models, Molecular; Molecular Structure; Rats; Xanthine Oxidase

2013
Molecular Docking Studies on Isocytosine Analogues as Xanthine Oxidase Inhibitors.
    Drug research, 2018, Volume: 68, Issue:7

    Topics: Catalytic Domain; Cytosine; Enzyme Inhibitors; Molecular Docking Simulation; Structure-Activity Relationship; Xanthine Oxidase

2018